Recent ECDC data show that despite progress in prevention and control efforts, the hepatitis B and hepatitis C viruses (HBV and HCV) continue to pose significant public health challenges in the European Union and European Economic Area (EU/EEA).
Resistance of Salmonella and Campylobacter bacteria to commonly used antimicrobials continues to be observed frequently in humans and animals, according to a report issued today by EFSA and ECDC.
During the 2023 West Nile virus transmission season, and as of 4 January 2024, 709 locally acquired human cases of West Nile virus infection, including 67 deaths, were reported by nine European Union countries.
As of 4 January 2024, 728 human cases of West Nile virus infection were reported, of which 709 were locally acquired and 19 were travel-associated. In 2023, seven EU countries reported 153 outbreaks among equids and eight EU countries reported 251 outbreaks among birds.
Distribution of human West Nile virus infections in NUTS 3 or GAUL 1 regions of the EU/EEA and neighbouring countries during 2013-2023, as of 4th January.
Distribution of human and animal West Nile virus infections in NUTS 3 or GAUL 1 regions of the EU/EEA and neighbouring countries during the 2023 season, as of 4th January.
The food-borne infections listeriosis and shigatoxigenic Escherichia coli are increasing in the EU/EEA and were in 2022 at levels higher than before the COVID-19 pandemic.